The approval of Aubagio was based on safety and efficacy data from the TEriflunomide Multiple Sclerosis Oral (TEMSO) trial. The immunomodulator with anti-inflammatory properties is the first once-daily,
The financing for the round was led by Merck Serono Ventures, the venture capital arm of Merck Serono. Canbex CEO Jesse Schulman said, "Spasticity is among the most
The collaboration agreed for a period of five years will focus on developing new evidence based formulations (EBFs) for added patient benefit. ICES executive director Dr Keith Carpenter
The integrated platform, which features 144,000 living tumor specimens, genomic databases and patient derived tumor models, will help drug development partners to minimise the research timelines. Drug Design
Previously, the US Secretary of Health and Human Services has asked the Food and Drug Administration (FDA) to reject Teva Pharmaceutical’s petition to make its Plan B and
The proof-of-concept trial was conducted with Activaero’s drug-device combination consisting of budesonide in liquid formulation and the company’s proprietary controlled inhalation system FAVORITE (Flow and Volume Controlled Inhalation
The US-based pharmaceutical company has appealed against the 5 April order that dismissed its plea for limiting Glenmark Pharmaceuticals from producing and marketing drugs Zita and Zita-Met indicated
The completion of construction will be followed by GMP certification at the provincial level, according to the company. The 53,000mt2 pre-extraction plant will perform initial processing of traditional
Operations at the 55,000ft2 GCP-compliant facility are expected to commence in August 2013. Novum chief executive officer Christopher Chamberlain said, "Like our other research facilities, it will provide
The grant will provide $2.2m over three years to develop a recombinant tetravalent dengue vaccine using VaxInnate’s proprietary technology, which includes genetically fusing vaccine antigens to the bacterial
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.